NEFL and myeloid sarcoma: - Significantly higher concentrations of NfL in PP/SPMS compared to RRMS patients and correlated with EDSS and MSSS (MS Severity Score); - increase of plasma NfL levels in PP/SPMS patients in a longitudinal sub-study; - no association between plasma NfL with prior/subsequent disability progression, as measured by EDSS